Table 1 Patient characteristics and response assessment
Sex | Age (yrs) | Genetic status | TTP (mo) | Survival (mo) | Metabolic response (modified EORTC) | Anatomic response (RECIST 1.0) |
|---|---|---|---|---|---|---|
Female | 79 | Exon 11 insertion PYD577-582 | 4.7 | 12.9 | PMR | PR |
Female | 61 | Exon 17 D820Y | 10.2 | 19. 3 | SMD | PR |
Female | 69 | Amplified | 7.4 | 8.8 | SMD | PD |
Male | 57 | Amplified | 5.0 | 11.5 | PMD | PD |
Female | 62 | Amplified | 2.6 | 11.9 | SMD | PD |
Male | 69 | Amplified | 5.8 | 16.2 | PMR | PD |
Female | 81 | Amplified | 1.0 | 3.8 | PMD | PD |
Female | 72 | Amplified | 1.3 | 9.8 | PMD | PD |
Female | 55 | Amplified | 10.6 | 18.3 | SMD | SD |
Female | 59 | Amplified | 0.9 | 2.8 | PMD | PD |
Female | 59 | Exon 11 L576P | 27.1 | 27.1 | PMR | PR |
Female | 75 | Amplified | 5.6 | 12.5 | PMD | SD |
Female | 47 | Exon 11 L576P | 2.6 | 7.3 | PMR | PR |
Male | 84 | Amplified | 1.6 | 21.8 | PMD | PD |
Female | 53 | Exon 11 deletion WKVVE557-560 | 10.6 | 24.3 | SMD | SD |
Male | 66 | Exon 13 K642E | 0.9 | 1.5 | PMD | PD |
Female | 66 | Exon 11 L576P | 3.4 | 5.5 | PMR | PR |